Prof. Dr. Faysal Dane

Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry

Anadolu Kliniği Tıp Bilimleri Dergisi, 2026

DOI 10.21673/anadoluklin.1675424 Açık erişimli tam metinKaynak: OpenAlex

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15020467 PMID 41598406 Açık erişimli tam metinKaynak: ORCID

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

Scientific Reports, 2025

DOI 10.1038/s41598-025-09707-3 PMID 40653542 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

Current Oncology, 2025

DOI 10.3390/curroncol32110639 PMID 41294701 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

KRAS Mutasyonu Saptanmayan Metastatik Kolorektal Kanserli Hastalarda Anti-EGFR Kullanımı-Ulusal Onco-Colon Çalışması Gerçek Yaşam Verleri

DergiPark (Istanbul University), 2025

Kaynak: OpenAlex

Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study

Medicina, 2025

DOI 10.3390/medicina61040694 PMID 40282985 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

P2.10.02 Developments in Treatment of Non-Small Cell Lung Cancer and Their Implications for National Practice.Registurk-Lung National Registry Study

Journal of Thoracic Oncology, 2025

DOI 10.1016/j.jtho.2025.09.696 Açık erişimli tam metinKaynak: OpenAlex

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

Cancers, 2024

DOI 10.3390/cancers16122251 PMID 38927957 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study

Cancers, 2024

DOI 10.3390/cancers16183213 PMID 39335184 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Evaluating the performance of the MSKCC gastric cancer survival calculator in the Turkish population

Turkish journal of medical sciences, 2024

DOI 10.55730/1300-0144.5901 PMID 39734332 Açık erişimli tam metinKaynak: Europe PMC

Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapy

Indian journal of cancer, 2024

DOI 10.4103/ijc.ijc_649_21 PMID 39960709 Açık erişimli tam metinKaynak: Europe PMC

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.16_suppl.e20512 Açık erişimli tam metinKaynak: OpenAlex

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Bursa Uludag University - AVESIS, 2024

Kaynak: OpenAlex

EE289 Cost of Hepatocellular Carcinoma in Türkiye: Results of a Delphi Panel Analysis

Value in Health, 2024

DOI 10.1016/j.jval.2024.10.571 Açık erişimli tam metinKaynak: OpenAlex

Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens

Oncology Letters, 2023

DOI 10.3892/ol.2023.13795 PMID 37123028 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters

Acta Radiologica, 2023

DOI 10.1177/02841851221140504 PMID 36447438 2 atıf (Europe PMC) Kaynak: ORCID

L’indice de comorbidité de Charlson ajusté selon l’âge est un outil pronostique précieux dans le sarcome des tissus mous opérable du tronc et des extrémités

Revue de Chirurgie Orthopédique et Traumatologique, 2023

DOI 10.1016/j.rcot.2022.11.016 Kaynak: OpenAlex

Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

Future Oncology, 2022

DOI 10.2217/fon-2021-1248 PMID 35081732 27 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey

Future Oncology, 2022

DOI 10.2217/fon-2022-0455 PMID 36040321 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy

Future oncology (London, England), 2022

DOI 10.2217/fon-2021-1322 PMID 35695547 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma

Balkan medical journal, 2022

DOI 10.5152/balkanmedj.2021.21122 PMID 34928235 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy

Revista Espanola de Medicina Nuclear E Imagen Molecular, 2022

DOI 10.1016/j.remn.2021.04.003 Kaynak: ORCID

Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment

Annals of Nuclear Medicine, 2022

DOI 10.1007/s12149-022-01785-x PMID 35997890 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities

Orthopaedics & Traumatology Surgery & Research, 2022

DOI 10.1016/j.otsr.2022.103491 PMID 36455864 6 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Impact of prognostic nutritional index on survival in recurrent glioblastoma

Neurocirugía (English Edition), 2022

DOI 10.1016/j.neucie.2020.11.004 PMID 34998488 4 atıf (OpenAlex) Kaynak: OpenAlex

The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers

Namık Kemal Tıp Dergisi, 2022

DOI 10.4274/nkmj.galenos.2021.52714 Açık erişimli tam metinKaynak: OpenAlex

Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data.

Journal of Clinical Oncology, 2022

DOI 10.1200/jco.2022.40.4_suppl.299 Kaynak: OpenAlex

Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.

Journal of Clinical Oncology, 2021

DOI 10.1200/jco.2021.39.15_suppl.e15561 Kaynak: OpenAlex

Metastatic cutaneous melanoma epidemiological registry in Turkey: A preliminary evaluation of diagnosis and treatment approaches

Bursa Uludag University - AVESIS, 2021

Kaynak: OpenAlex

A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients with HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study

American Journal of Clinical Oncology: Cancer Clinical Trials, 2021

DOI 10.1097/coc.0000000000000825 PMID 33979100 17 atıf (Europe PMC) Kaynak: ORCID

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

International Journal of Colorectal Disease, 2021

DOI 10.1007/s00384-021-03888-9 PMID 33586012 28 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

A rare case of gastric cancer with bilateral breast metastasis during pregnancy

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/1078155220925156 PMID 32448025 8 atıf (Europe PMC) Kaynak: ORCID

Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2021

DOI 10.1016/j.remnie.2021.05.007 PMID 35577492 4 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Impact of prognostic nutritional index on survival in recurrent glioblastoma

Neurocirugía, 2021

DOI 10.1016/j.neucir.2020.11.005 PMID 33454185 5 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

P47.14 Clinicopathologic Features of Large Cell Neuroendocrine Carcinoma of Lung

Journal of Thoracic Oncology, 2021

DOI 10.1016/j.jtho.2021.01.870 Açık erişimli tam metinKaynak: OpenAlex

Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220920684 PMID 32349641 5 atıf (Europe PMC) Kaynak: OpenAlex

Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

Journal of Oncological Sciences, 2020

DOI 10.37047/jos.2020-75080 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220963535 PMID 33050804 Kaynak: OpenAlex

Multicenter real life expeMulticenter real life experience of biological agents in patients with metastatic colorectal cancerrience of biological agents in patients with metastatic colorectal cancer

2020

Kaynak: OpenAlex

Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma

Tumori Journal, 2020

DOI 10.1177/0300891620950475 PMID 32878562 5 atıf (Europe PMC) Kaynak: OpenAlex

Opere Erken Evre Akciğer Kanseri Hastalarında Prognostik Faktörler Retrospektif Tek Merkez Sonuçları

Namık Kemal Tıp Dergisi, 2020

DOI 10.37696/nkmj.715690 Açık erişimli tam metinKaynak: OpenAlex

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

BMJ Open, 2020

DOI 10.1136/bmjopen-2018-027665 PMID 32220908 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

BMC Cancer, 2020

DOI 10.1186/s12885-020-06758-9 PMID 32228512 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer

Current Problems in Cancer, 2020

DOI 10.1016/j.currproblcancer.2020.100594 PMID 32505368 6 atıf (Europe PMC) Kaynak: ORCID

Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer

Nutrition and Cancer, 2020

DOI 10.1080/01635581.2020.1749290 PMID 32270713 62 atıf (OpenAlex) Kaynak: OpenAlex

VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature

Current Problems in Cancer, 2020

DOI 10.1016/j.currproblcancer.2020.100568 PMID 32201052 14 atıf (Europe PMC) Kaynak: ORCID

18F-FDG PET/CT findings of a rare case of diffuse hepatic epithelioid hemangioendothelioma with bone metastases at diagnosis

Revista Espanola de Medicina Nuclear E Imagen Molecular, 2020

DOI 10.1016/j.remn.2019.05.007 PMID 31594699 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature

Current Problems in Cancer, 2020

DOI 10.1016/j.currproblcancer.2020.100668 PMID 33127167 11 atıf (OpenAlex) Kaynak: OpenAlex

Does insulin resistance predict complete response in breast cancer patients who underwent neoadjuvant treatment?

Cancer Research, 2020

DOI 10.1158/1538-7445.sabcs19-p2-16-18 Kaynak: ORCID

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

World Journal of Surgical Oncology, 2020

DOI 10.1186/s12957-020-02019-y PMID 32907593 25 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID